Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder

Background: The evaluation of treatment response to antidepressant therapy commonly depends on neuropsychologic assessments, as there are currently no suitable biomarkers. Previous research has identified a panel of increased proteins in patients with major depressive disorder (MDD), including antit...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ruize, Shi, Yachen, Li, Xianrui, Zhu, Jianli, Zhang, Hongxing, Li, Kun, Wang, Bi, Zhang, Haisan, Yang, Yongfeng, Gao, Lijuan, Zhao, Yang, Zhang, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580946/
https://www.ncbi.nlm.nih.gov/pubmed/34777034
http://dx.doi.org/10.3389/fpsyt.2021.678384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580946/
https://www.ncbi.nlm.nih.gov/pubmed/34777034
http://dx.doi.org/10.3389/fpsyt.2021.678384

Ejemplares similares